title: Smoking increases oral HPV persistence among men: 7-year follow-up study.
abstract: Persistent high-risk human papillomavirus (HR-HPV) infection is the key event in the progression of HPV lesions, and more data are urgently needed on asymptomatic oral HPV infections in men. Asymptomatic fathers-to-be (n = 131, mean age 28.9 years) were enrolled in the cohort, sampled by serial oral scrapings at baseline and at 2-month, 6-month, 12-month, 24-month, 36-month, and 7-year follow-up visits to accomplish persistent and cleared HPV infections. HPV genotyping was performed using nested PCR and Multimetrix® assay. Covariates of persistent and cleared oral HPV infections were analysed using generalised estimating equation (GEE) and Poisson regression. Altogether, 17 HPV genotypes were detected in male oral mucosa point prevalence, varying from 15.1 % to 31.1 %. Genotype-specific HPV persistence was detected in 18/129 men the mean persistence time ranging from 6.0 to 30.7 months. History of genital warts decreased (p = 0.0001; OR = 0.41, 95 % CI 0.33-0.51) and smoking increased (p = 0.033, OR = 1.92, 95 % CI 1.05-3.50) the risk of persistent species 7/9 HPV infections. Of the 74 HPV-positive men, 71.6 % cleared their infection actuarial and crude clearance times, varying between 1.4 and 79.6 months. No independent predictors were identified for species 7/9 clearance. At the last follow-up-visit, 50.1 % of the fathers had oral mucosal changes, correlating only with smoking (p = 0.046). To conclude, most of the persisting oral infections in males were caused by HPV16. Smoking increased while previous genital warts decreased oral HR-HPV persistence. No predictors of HR-HPV clearance were disclosed.
authors.affiliation: Department of Obstetrics and Gynecology, Turku University Hospital, University of Turku, P.O. Box 52, 20521, Turku, Finland, katja.kero@utu.fi.
authors.forename: K
authors.initials: K
authors.lastname: Kero
authors.forename: J
authors.initials: J
authors.lastname: Rautava
authors.forename: K
authors.initials: K
authors.lastname: Syrjänen
authors.forename: J
authors.initials: J
authors.lastname: Willberg
authors.forename: S
authors.initials: S
authors.lastname: Grenman
authors.forename: S
authors.initials: S
authors.lastname: Syrjänen
mesh_terms: D000328:Adult; D002353:Carrier State / Q000453:epidemiology* / Q000821:virology*; D015331:Cohort Studies; D004279:DNA, Viral / Q000235:genetics; D005500:Follow-Up Studies; D005838:Genotype; D060005:Genotyping Techniques; D006801:Humans; D008297:Male; D009061:Mouth Mucosa / Q000821:virology*; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000821:virology*; D016133:Polymerase Chain Reaction; D011446:Prospective Studies; D012907:Smoking / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D004279:DNA, Viral
references.citation: Head Neck Pathol. 2012 Jul;6 Suppl 1:S3-15
references.pmid: 22782219
references.citation: PLoS One. 2012;7(8):e42171
references.pmid: 22952591
references.citation: J Clin Microbiol. 2010 Aug;48(8):2665-71
references.pmid: 20554830
references.citation: Semin Oncol. 2004 Dec;31(6):744-54
references.pmid: 15599852
references.citation: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references.pmid: 3344216
references.citation: Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):172-82
references.pmid: 21148755
references.citation: Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):122-33
references.pmid: 22045700
references.citation: BMC Infect Dis. 2011 May 25;11:150
references.pmid: 21612634
references.citation: Clin Microbiol Rev. 2012 Apr;25(2):215-22
references.pmid: 22491770
references.citation: J Infect Dis. 2009 May 1;199(9):1263-9
references.pmid: 19320589
references.citation: Eur Urol. 2012 Dec;62(6):1063-70
references.pmid: 22771267
references.citation: N Engl J Med. 2007 May 10;356(19):1993-5
references.pmid: 17494934
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75
references.pmid: 15734974
references.citation: Periodontol 2000. 2005;37:124-37
references.pmid: 15655029
references.citation: J Sex Med. 2011 Sep;8(9):2522-31
references.pmid: 21718450
references.citation: J Clin Microbiol. 2006 Feb;44(2):504-12
references.pmid: 16455905
references.citation: Oral Microbiol Immunol. 1999 Aug;14(4):201-5
references.pmid: 10551162
references.citation: BMC Infect Dis. 2011 Jun 22;11:179
references.pmid: 21696607
references.citation: Scand J Infect Dis. 2012 Feb;44(2):115-25
references.pmid: 22053923
references.citation: Sex Transm Dis. 2012 Jul;39(7):559-66
references.pmid: 22706220
references.citation: J Clin Microbiol. 2005 Jan;43(1):376-81
references.pmid: 15634997
references.citation: Cancer Res. 1989 Sep 1;49(17):4677-81
references.pmid: 2547512
references.citation: JAMA. 2012 Feb 15;307(7):693-703
references.pmid: 22282321
references.citation: Int J Cancer. 2007 Jul 1;121(1):143-50
references.pmid: 17354235
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jul;98(1):91-6
references.pmid: 15243477
references.citation: J Clin Virol. 2006 Jan;35(1):89-94
references.pmid: 16112613
references.citation: PLoS One. 2013;8(1):e53413
references.pmid: 23301068
references.citation: J Infect Dis. 2010 Aug 15;202(3):436-44
references.pmid: 20557239